Autosomal Dominant Polycystic Kidney Disease Does Not Significantly Alter Major COVID-19 Outcomes among Veterans. Issue 6 (24th June 2021)

• Record Type: Journal Article
• Authors: Cui, Xiangqin; Gallini, Julia W.; Jasien, Christine L.; Mrug, Michal
• Is Part Of: Kidney360. Volume 2:Issue 6(2021)
• Page Start: 983
• Page End: 988
• Publication Date: 2021-06-24
• Subjects: cystic kidney disease -- chronic kidney disease -- coronavirus disease 2019 -- COVID-19 -- hospital admission -- ICU admission -- kidney failure -- mortality -- polycystic kidney disease -- SARS-CoV-2 -- ventilator -- veterans; 616.61
• DOI: 10.34067/KID.0007282020
• Languages: English
• ISSNs: 2641-7650

Abstract

Abstract : Key Points: Autosomal dominant polycystic kidney disease (ADPKD) was not a significant, independent risk factor for the four major outcomes studied among veterans with confirmed coronavirus disease 2019 (COVID-19). ADPKD did not significantly increase the risk for newly starting dialysis (after controlling for CKD) among veterans positive for COVID-19. The established risk factors for severe COVID-19 illness had significant effects in this cohort ( e.g., type 2 diabetes and Black race).